Axorn Co FC Tablet

Axorn Co FC Tablet

S4


Clinical Summary

Quick overview from the medicine insert

Indication

Management of hypertension and heart failure.

Dosage (summary)

The usual starting dose is 80 mg/12.5 mg once daily, which may be adjusted based on blood pressure response. Maximum dose can be 320 mg/25 mg once daily.

Onset of Action / Duration

Antihypertensive effects can be observed within 2 weeks of starting treatment, with maximum effect typically seen after 4-6 weeks.

Special Populations

  • Elderly patients may require dose adjustment.
  • Patients with renal impairment should be monitored closely.
  • Patients with hepatic impairment should use with caution.

Pregnancy & Breastfeeding

Use is contraindicated during pregnancy and lactation due to potential harm to the fetus and nursing infant.

Key Drug Interactions

  • Potassium-sparing diuretics may increase the risk of hyperkalemia.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect.
  • Other antihypertensive agents may have additive effects.

Contraindications

  • Hypersensitivity to valsartan, hydrochlorothiazide, or any component of the formulation.
  • Severe renal impairment.
  • Anuria.
  • Pregnancy and lactation.

Common side effects

  • Dizziness.
  • Fatigue.
  • Hypotension.
  • Electrolyte imbalances (e.g., hypokalemia, hyperkalemia).
  • Renal impairment.

Counselling Points

  • Take the medication at the same time each day.
  • Monitor blood pressure regularly.
  • Report any signs of allergic reactions, such as rash or swelling.
  • Maintain adequate hydration and electrolyte balance.

Serious warnings

  • Monitor renal function periodically.
  • Caution in patients with a history of angioedema.
  • Discontinue if pregnancy is detected.
Important Disclaimer

The Axorn Co FC Tablet professional information leaflet below is the property of Aurogen Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites